ENTA Enanta Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 12, 2026
$12,96
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$10,1252tyg. minimum
$17,1552tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$377M
P/E (TTM)
-5.4
EPS (TTM)
$-2.42
Przychody (TTM)
$65M
Twoje odznaki
Zakres 52 tyg.
$10–$17
Ocena Analityków
BUY
Cena Docelowa
$22
P/E
-5.4
ROE
-70.1%
Marża Zysku Netto
-96.9%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
ENTA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$12.96
Kapitalizacja Rynkowa (MRQ)
$377M
P/E (TTM)
-5.4
EPS (TTM)
$-2.42
Przychody (TTM)
$65M
ROE (TTM)
-70.1%
Zakres 52 tyg.
$10–$17
ENTA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$65M2016-09-30 → 2025-09-30
EPS$-3.842016-09-30 → 2025-09-30
Wolny przepływ pieniężny$-32M2017-09-30 → 2025-09-30
Marża netto-96.9%2017-09-30 → 2025-09-30
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | ENTA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -5.4średnia z 5 lat ≈-6.0 | ≈-6.0 | · | · | |
| P/S (TTM) | 5.8średnia z 5 lat ≈6.9 | ≈6.9 | 51.3 | Niedowartościowany | |
| P/B (MRQ) | 3.7średnia z 5 lat ≈2.6 | ≈2.6 | 2.4 | Zawyżona wycena | |
| Cena / FCF (TTM) | -10.2średnia z 5 lat ≈-8.2 | ≈-8.2 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -10.7średnia z 5 lat ≈-9.5 | ≈-9.5 | · | · | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 4.3średnia z 5 lat ≈2.6 | ≈2.6 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | ENTA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -90.0%średnia z 5 lat ≈-148.1% | ≈-148.1% | -683.0% | Najwyższa półka | |
| EBITDA Margin (Marża EBITDA) | -130.7%średnia z 5 lat ≈-148.1% | ≈-148.1% | -683.0% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | -96.7%średnia z 5 lat ≈-144.0% | ≈-144.0% | -459.4% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | -96.9%średnia z 5 lat ≈-137.7% | ≈-137.7% | -673.2% | Najwyższa półka | |
| ROA (TTM) | -21.2%średnia z 5 lat ≈-26.3% | ≈-26.3% | -36.6% | Najwyższa półka | |
| ROE (TTM) | -70.1%średnia z 5 lat ≈-60.4% | ≈-60.4% | -47.7% | Słaby | |
| ROIC | -129.3%średnia z 5 lat ≈-69.1% | ≈-69.1% | -46.7% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | ENTA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 3.8średnia z 5 lat ≈7.1 | ≈7.1 | 8.3 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.8średnia z 5 lat ≈1.5 | ≈1.5 | 5.9 | Niska płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | ENTA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -3.4%średnia z 5 lat ≈-11.6% | ≈-11.6% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -8.8%średnia z 5 lat ≈-11.2% | ≈-11.2% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -11.8% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | ENTA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.2średnia z 5 lat ≈0.2 | ≈0.2 | 0.0 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 9.7średnia z 5 lat ≈6.4 | ≈6.4 | · | · | |
| Revenue / Employee (Przychody / pracownika) | ≈$544.4K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
14.9%
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 10, 2026 | $-0.67 | $-0.52 | -28.8% |
| 31 marca 2026 | $-0.45 | $-0.50 | 9.6% | |
| 31 grudnia 2025 | $-0.42 | $-0.82 | 49.0% | |
| 30 września 2025 | $-0.87 | $-1.04 | 16.5% | |
| 30 czerwca 2025 | $-0.85 | $-1.30 | 34.7% | |
| 31 marca 2025 | $-1.06 | $-1.16 | 8.5% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $68M | $79M | $86M | $97M | $122M | $205M | $207M | $103M | $88M | $161M | $48M | |
| R&D Expense | $107M | $131M | $164M | $165M | $174M | $137M | $142M | $95M | $57M | $40M | $23M | $19M | |
| SG&A Expense | $44M | $58M | $53M | $45M | $33M | $27M | $26M | $23M | $21M | $17M | $14M | $10M | |
| Operating Expenses | $151M | $189M | $216M | $210M | $207M | $164M | $168M | $118M | $78M | $57M | $37M | $29M | |
| Operating Income | $-85M | $-122M | $-137M | $-124M | $-110M | $-42M | $37M | $88M | $25M | $31M | $124M | $19M | |
| Interest Expense | · | · | $5M | $0 | $0 | · | · | · | $40.0K | $45.0K | $8.0K | $18.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $2M | $968.0K | $467.0K | |
| Other Non-op | $2M | $4M | $6M | $2M | $2M | $7M | $9M | $5M | $2M | $2M | · | · | |
| Pretax Income | $-84M | $-118M | $-131M | $-122M | $-108M | $-35M | $46M | $93M | $27M | $33M | $125M | $19M | |
| Income Tax | $-2M | $-2M | $3M | $-433.0K | $-29M | $1M | $-826.0K | $21M | $9M | $11M | $46M | $-15M | |
| Net Income | $-82M | $-116M | $-134M | $-122M | $-79M | $-36M | $46M | $72M | $18M | $22M | $79M | $34M | |
| EPS (Basic) | $-3.84 | $-5.48 | $-6.38 | $-5.91 | $-3.92 | $-1.81 | $2.37 | $3.74 | $0.93 | $1.14 | $4.23 | $1.88 | |
| EPS (Diluted) | $-3.84 | $-5.48 | $-6.38 | $-5.91 | $-3.92 | $-1.81 | $2.21 | $3.48 | $0.91 | $1.13 | $4.09 | $1.80 | |
| Shares (Basic) | 21,336 | 21,157 | 20,969 | 20,603 | 20,171 | 19,940 | 19,584,000 | 19,255,000 | 19,066,000 | 18,929,000 | 18,673,000 | 18,355 | |
| Shares (Diluted) | 21,336 | 21,157 | 20,969 | 20,603 | 20,171 | 19,940 | 20,968,000 | 20,650,000 | 19,407,000 | 19,224,000 | 19,295,000 | 19,185 | |
| EBITDA | $-85M | $-122M | $-137M | $-124M | $-110M | $-42M | $37M | $88M | $25M | · | $124M | $19M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $37M | $85M | $44M | $57M | $87M | $51M | $64M | $66M | $17M | $22M | $31M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $158M | $194M | $123M | $60M | |
| Receivables | $7M | $7M | $9M | $20M | $24M | $23M | $51M | $67M | $11M | $13M | $15M | $2M | |
| Prepaid Expense | $9M | $12M | $13M | $13M | $14M | $14M | $15M | $4M | $4M | $9M | $8M | $2M | |
| Current Assets | $204M | $300M | $423M | $312M | $319M | $437M | $402M | $380M | $238M | $232M | $171M | $108M | |
| PP&E (Net) | $35M | $33M | $12M | $6M | $6M | $9M | $11M | $8M | $8M | $8M | $6M | $2M | |
| PP&E (Gross) | $59M | $58M | $36M | $28M | $25M | $24M | $23M | $17M | $15M | $13M | $10M | $6M | |
| Accum. Depreciation | $24M | $25M | $24M | $22M | $19M | $16M | $12M | $9M | $7M | $5M | $4M | $4M | |
| Other Non-current Assets | $92.0K | $94.0K | $803.0K | $696.0K | $92.0K | $92.0K | $92.0K | $92.0K | · | · | · | · | |
| Total Assets | $281M | $377M | $462M | $375M | $439M | $486M | $490M | $414M | $327M | $281M | $246M | $155M | |
| Accounts Payable | $2M | $8M | $4M | $6M | $10M | $6M | $7M | $5M | $4M | $3M | $2M | $2M | |
| Accrued Liabilities | $13M | $14M | $18M | $21M | $22M | $14M | $16M | $10M | $8M | $5M | $4M | $3M | |
| Current Liabilities | $49M | $58M | $63M | $30M | $36M | $24M | $23M | $16M | $21M | $8M | $7M | $5M | |
| Capital Leases | $55M | $54M | $21M | $22M | $1M | $4M | $200.0K | $293.0K | $379.0K | $458.0K | $529.0K | · | |
| Other Non-current Liabilities | $260.0K | $231.0K | $663.0K | $454.0K | $558.0K | $1M | $3M | $3M | $2M | $2M | $2M | $229.0K | |
| Total Liabilities | $216M | $248M | $246M | $54M | $39M | $31M | $27M | $21M | $25M | $11M | $10M | $7M | |
| Common Stock | $214.0K | $212.0K | $211.0K | $208.0K | $202.0K | $201.0K | $197.0K | $194.0K | $191.0K | $190.0K | $187.0K | $188.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $222M | |
| Retained Earnings | $-405M | $-323M | $-207M | $-73M | $49M | $128M | $164M | $117M | $45M | $28M | $6M | $-73M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| AOCI | $-339.0K | $302.0K | $-1M | $-4M | $-382.0K | $844.0K | $146.0K | $-398.0K | $-112.0K | $19.0K | $33.0K | $-100.0K | |
| Stockholders' Equity | $65M | $129M | $217M | $321M | $399M | $456M | $462M | $394M | $302M | $270M | $236M | $149M | |
| Liabilities + Equity | $281M | $377M | $462M | $375M | $439M | $486M | $490M | $414M | $327M | $281M | $246M | $155M | |
| Shares Outstanding | 21,387,000 | 21,387,000 | 21,059,000 | 20,791,000 | 20,238,000 | 20,077,000 | 19,703,000 | 19,395,000 | 19,120,000 | 19,036,000 | 18,716,834 | 18,594,574 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $2M | $2M | $639.0K | $352.0K | |
| Stock-based Comp | $19M | $27M | $28M | $27M | $21M | $20M | $19M | $16M | $13M | $9M | $6M | $3M | |
| Deferred Tax | · | · | · | · | · | $-18M | · | · | · | · | · | $-15M | |
| Operating Cash Flow | $-19M | $-79M | $-103M | $-85M | $-70M | $7M | $71M | $29M | $53M | $36M | $77M | $20M | |
| CapEx | $13M | $18M | $9M | $2M | $750.0K | $1M | $5M | $3M | $3M | $5M | $2M | $1M | |
| Investing Cash Flow | $40M | $58M | $-54M | $55M | $37M | $20M | $-87M | $-35M | $-5M | $-44M | · | · | |
| Financing Cash Flow | $-27M | $-28M | $198M | $20M | $3M | $9M | $3M | $4M | $1M | $3M | · | · | |
| Net Change in Cash | $-6M | $-48M | $41M | $-10M | $-30M | $36M | $-13M | $-2M | $49M | $-5M | $-9M | $22M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $13M | $40M | $148.0K | |
| Free Cash Flow | $-32M | $-97M | $-112M | $-87M | $-71M | $6M | $66M | $26M | $50M | · | $74M | $19M | |
| Levered FCF | · | · | $-117M | · | · | · | · | · | $50M | · | $74M | $19M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -130.7% | -179.9% | -173.2% | -143.7% | -112.9% | -34.0% | 17.9% | 42.8% | 23.9% | · | 77.2% | 39.8% | |
| Net Margin | -125.4% | -171.6% | -168.9% | -141.3% | -81.4% | -29.5% | 22.6% | 34.8% | 17.2% | · | 49.1% | 72.1% | |
| Pretax Margin | -127.9% | -174.2% | -165.4% | -141.8% | -110.8% | -28.6% | 22.2% | 45.1% | 26.2% | · | 78.0% | 40.4% | |
| EBITDA Margin | -130.7% | -179.9% | -173.2% | -143.7% | -112.9% | -34.0% | 17.9% | 42.8% | 23.9% | · | 77.2% | 39.8% | |
| ROA | -24.9% | -27.7% | -31.9% | -29.9% | -17.1% | -7.4% | 10.3% | 19.4% | 5.8% | · | 39.4% | 25.3% | |
| ROE | -103.5% | -83.6% | -58.9% | -36.9% | -19.3% | -7.7% | 10.2% | 19.1% | 6.2% | · | 41.0% | 26.6% | |
| ROIC | -129.3% | -93.1% | -64.7% | -38.4% | -20.1% | -9.4% | 8.1% | 17.3% | 5.4% | · | 33.1% | 22.8% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | 5.2 | 6.7 | 10.5 | 8.8 | 18.1 | 17.8 | 23.7 | 11.3 | · | 25.5 | 22.8 | |
| Quick Ratio | 0.8 | 0.8 | 1.5 | 2.2 | 2.2 | 4.6 | 4.5 | 8.2 | 11.2 | · | 23.9 | 19.5 | |
| Interest Coverage | · | · | -26.7 | · | · | · | · | · | 615.4 | · | 15518.5 | 1054.7 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.5 | 0.6 | 0.3 | · | 0.8 | 0.4 | |
| Receivables Turnover | 9.7 | 8.9 | 5.5 | 3.9 | 4.1 | 3.3 | 3.5 | 5.3 | 8.8 | · | 18.9 | 37.7 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.03 | $6.08 | $10.29 | $15.46 | $19.74 | $22.69 | $23.47 | $20.30 | $15.78 | · | $12.62 | $7.99 | |
| Revenue / Share | $3061.68 | $3196.81 | $3777.19 | $4181.92 | $4.81 | $6.14 | $9.79 | $10.01 | $5.30 | · | $8.34 | $2.49 | |
| Cash Flow / Share | $-903.26 | $-3722.83 | $-4919.36 | $-4115.03 | $-3.47 | $0.36 | $3.41 | $1.42 | $2.71 | · | $3.97 | $1.05 | |
| Cash / Share | $1.51 | $1.76 | $4.05 | $2.12 | $2.83 | $4.34 | $2.60 | $3.29 | $3.43 | · | $1.16 | $1.65 | |
| EPS (TTM) | $-3.84 | $-5.48 | $-6.38 | $-5.91 | $-3.92 | $-1.81 | $2.21 | $3.48 | $0.91 | $1.13 | $4.09 | $1.80 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.4% | -14.6% | -8.1% | -11.2% | -20.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | -11.3% | -13.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -11.8% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $65M | $68M | $79M | $86M | $97M | $122M | $205M | $207M | $103M | $88M | $161M | $48M | |
| Net Income TTM | $-82M | $-116M | $-134M | $-122M | $-79M | $-36M | $46M | $72M | $18M | $22M | $79M | $34M | |
| Market Cap | $256M | $220M | $235M | $1.08B | $1.15B | $919M | $1.18B | $1.66B | $895M | · | $676M | $736M | |
| P/E | -3.1 | -1.9 | -1.8 | -8.8 | -14.5 | -25.3 | 27.2 | 24.6 | 51.4 | 23.5 | 8.8 | 22.0 | |
| P/S | 3.9 | 3.2 | 3.0 | 12.5 | 11.8 | 7.5 | 5.8 | 8.0 | 8.7 | · | 4.2 | 15.4 | |
| P/B | 4.0 | 1.7 | 1.1 | 3.4 | 2.9 | 2.0 | 2.6 | 4.2 | 3.0 | · | 2.9 | 4.9 | |
| P / Tangible Book | 4.0 | 1.7 | 1.1 | 3.4 | 2.9 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | -13.3 | -2.8 | -2.3 | -12.7 | -16.4 | 129.7 | 16.6 | 56.7 | 17.0 | · | 8.8 | 36.5 | |
| P / FCF | -8.0 | -2.3 | -2.1 | -12.4 | -16.3 | 162.9 | 17.9 | 63.2 | 17.8 | · | 9.1 | 38.4 | |
| Earnings Yield | -32.1% | -52.9% | -57.1% | -11.4% | -6.9% | -4.0% | 3.7% | 4.1% | 1.9% | 4.2% | 11.3% | 4.5% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $17M | $19M | $15M | $18M | $15M | $17M | $15M | $18M | $17M | $18M | $19M | $19M | $18M | $24M | $20M | |
| R&D Expense | $22M | $19M | $21M | $24M | $27M | $28M | $28M | $31M | $29M | $36M | $36M | $36M | $43M | $43M | $41M | $35M | |
| SG&A Expense | $9M | $10M | $9M | $10M | $10M | $11M | $13M | $14M | $13M | $14M | $17M | $14M | $13M | $14M | $13M | $13M | |
| Operating Expenses | $32M | $29M | $30M | $34M | $37M | $39M | $41M | $44M | $42M | $50M | $53M | $50M | $56M | $57M | $54M | $47M | |
| Operating Income | $-17M | $-12M | $-11M | $-18M | $-19M | $-25M | $-24M | $-30M | $-24M | $-33M | $-35M | $-31M | $-37M | $-39M | $-30M | $-27M | |
| Interest Expense | · | · | · | · | · | · | · | · | $2M | $3M | $3M | · | $2M | $0 | $0 | · | |
| Other Non-op | $-2M | $-1M | $-661.0K | $-282.0K | $667.0K | $578.0K | $837.0K | $668.0K | $1M | $1M | $857.0K | $2M | $2M | $2M | $993.0K | $750.0K | |
| Pretax Income | $-19M | $-13M | $-12M | $-19M | $-18M | $-24M | $-23M | $-29M | $-23M | $-32M | $-34M | $-30M | $-35M | $-38M | $-29M | $-26M | |
| Income Tax | $36.0K | $7.0K | $24.0K | $32.0K | $29.0K | $-1M | $-416.0K | $-363.0K | $-395.0K | $-363.0K | $-622.0K | $-1M | $4M | $44.0K | $-34.0K | $50.0K | |
| Net Income | $-20M | $-13M | $-12M | $-19M | $-18M | $-23M | $-22M | $-29M | $-23M | $-31M | $-33M | $-28M | $-39M | $-38M | $-29M | $-26M | |
| EPS (Basic) | $-0.67 | $-0.45 | $-0.42 | $-0.88 | $-0.85 | $-1.06 | $-1.05 | $-1.36 | $-1.07 | $-1.47 | $-1.58 | $-1.34 | $-1.86 | $-1.79 | $-1.39 | $-1.27 | |
| EPS (Diluted) | $-0.67 | $-0.45 | $-0.42 | $-0.88 | $-0.85 | $-1.06 | $-1.05 | $-1.36 | $-1.07 | $-1.47 | $-1.58 | $-1.34 | $-1.86 | $-1.79 | $-1.39 | $-1.27 | |
| Shares (Basic) | 29,090,000 | 29,040,000 | 28,748,000 | · | 21,377,000 | 21,355,000 | 21,238,000 | · | 21,180,000 | 21,167,000 | 21,088,000 | · | 21,054,000 | 21,035,000 | 20,816,000 | · | |
| Shares (Diluted) | 29,090,000 | 29,040,000 | 28,748,000 | · | 21,377,000 | 21,355,000 | 21,238,000 | · | 21,180,000 | 21,167,000 | 21,088,000 | · | 21,054,000 | 21,035,000 | 20,816,000 | · | |
| EBITDA | $-17M | $-12M | $-11M | · | $-19M | $-25M | $-24M | · | $-24M | $-33M | $-35M | · | $-37M | $-39M | $-30M | · |
Bilans
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $33M | $35M | $37M | $32M | $45M | $60M | $84M | $37M | $36M | $64M | $40M | · | $95M | $73M | $42M | · | |
| Receivables | $7M | $8M | $8M | $7M | $8M | $7M | $8M | $7M | $8M | $8M | $8M | · | $19M | $18M | $23M | · | |
| Prepaid Expense | $8M | $7M | $4M | $9M | $10M | $9M | $11M | $12M | $15M | $11M | $13M | · | $17M | $14M | $18M | · | |
| Current Assets | $204M | $178M | $199M | $204M | $223M | $243M | $268M | $300M | $287M | $351M | $390M | · | $448M | $271M | $284M | · | |
| PP&E (Net) | $32M | $33M | $34M | $35M | $37M | $38M | $37M | $33M | $25M | $15M | $12M | · | $12M | $11M | $9M | · | |
| PP&E (Gross) | · | · | · | $59M | $59M | $59M | $57M | $58M | $50M | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $24M | $23M | $21M | $20M | $25M | $25M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $110.0K | $144.0K | $93.0K | $92.0K | $94.0K | $98.0K | $94.0K | $94.0K | $105.0K | $187.0K | $765.0K | · | $830.0K | $696.0K | $701.0K | · | |
| Total Assets | $297M | $315M | $330M | $281M | $301M | $323M | $349M | $377M | $399M | $414M | $428M | · | $495M | $326M | $348M | · | |
| Accounts Payable | $3M | $4M | $2M | $2M | $4M | $5M | $5M | $8M | $11M | $7M | $9M | · | $8M | $12M | $4M | · | |
| Accrued Liabilities | $10M | $7M | $8M | $13M | $11M | $8M | $11M | $14M | $13M | $11M | $12M | · | $18M | $15M | $15M | · | |
| Current Liabilities | $54M | $46M | $45M | $49M | $45M | $46M | $49M | $58M | $58M | $55M | $62M | · | $68M | $32M | $23M | · | |
| Capital Leases | $52M | $53M | $54M | $55M | $56M | $57M | $56M | $54M | $48M | $43M | $21M | · | $22M | $23M | $22M | · | |
| Other Non-current Liabilities | $286.0K | $278.0K | $269.0K | $260.0K | $252.0K | $243.0K | $235.0K | $231.0K | $227.0K | $224.0K | $649.0K | · | $426.0K | $408.0K | $414.0K | · | |
| Total Liabilities | $196M | $198M | $203M | $216M | $222M | $229M | $237M | $248M | $250M | $247M | $237M | · | $257M | $57M | $47M | · | |
| Common Stock | $291.0K | $291.0K | $290.0K | $214.0K | $214.0K | $214.0K | $213.0K | $212.0K | $212.0K | $212.0K | $212.0K | · | $210.0K | $210.0K | $209.0K | · | |
| Retained Earnings | $-449M | $-430M | $-417M | $-405M | $-386M | $-368M | $-345M | $-323M | $-294M | $-272M | $-240M | · | $-179M | $-140M | $-102M | · | |
| AOCI | $-927.0K | $-734.0K | $-329.0K | $-339.0K | $-402.0K | $-224.0K | $-29.0K | $302.0K | $-653.0K | $-667.0K | $-534.0K | · | $-2M | $-2M | $-3M | · | |
| Stockholders' Equity | $101M | $117M | $127M | $65M | $79M | $94M | $112M | $129M | $149M | $166M | $192M | $217M | $238M | $269M | $301M | $321M | |
| Liabilities + Equity | $297M | $315M | $330M | $281M | $301M | $323M | $349M | $377M | $399M | $414M | $428M | · | $495M | $326M | $348M | · | |
| Shares Outstanding | 29,120,000 | 29,061,000 | 29,019,000 | 21,387,000 | 21,378,000 | 21,377,000 | 21,333,000 | 21,194,000 | 21,182,000 | 21,179,000 | 21,156,000 | · | 21,056,000 | 21,049,000 | 20,884,000 | · |
Przepływy pieniężne
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $889.0K | $479.0K | $594.0K | $621.0K | $642.0K | $669.0K | $651.0K | $540.0K | $511.0K | $655.0K | |
| Stock-based Comp | $4M | $4M | $4M | $4M | $4M | $5M | $6M | $8M | $5M | $6M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Operating Cash Flow | $-10M | $-7M | $-12M | $-6M | $18M | $-13M | $-17M | $-10M | $-15M | $-29M | $-25M | $-22M | $-32M | $-14M | $-36M | $-16M | |
| CapEx | $7.0K | $15.0K | $143.0K | $1M | $155.0K | $3M | $9M | $9M | $7M | $2M | $787.0K | $1M | $2M | $2M | $3M | $1M | |
| Investing Cash Flow | $14M | $12M | $-47M | $2M | $-26M | $-4M | $69M | $19M | $-6M | $59M | $-13M | $12M | $-146M | $47M | $34M | $28M | |
| Financing Cash Flow | $-6M | $-7M | $64M | $-8M | $-6M | $-7M | $-5M | $-7M | $-7M | $-6M | $-7M | $-23.0K | $200M | $-2M | $301.0K | $3M | |
| Net Change in Cash | $-2M | $-3M | $5M | $-13M | $-15M | $-25M | $47M | $1M | $-28M | $24M | $-45M | $-10M | $22M | $31M | $-2M | $16M | |
| Free Cash Flow | · | · | $-12M | · | · | · | $-26M | · | · | · | $-26M | · | · | · | $-39M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-29M | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -120.0% | -69.1% | -60.5% | · | -103.2% | -164.3% | -138.8% | · | -134.6% | -192.1% | -193.8% | · | -194.3% | -221.7% | -127.2% | · | |
| Net Margin | -135.8% | -76.3% | -64.1% | · | -99.7% | -151.7% | -131.4% | · | -126.1% | -182.7% | -185.6% | · | -206.8% | -211.6% | -122.9% | · | |
| Pretax Margin | -135.6% | -76.2% | -64.0% | · | -99.5% | -160.5% | -133.9% | · | -128.3% | -184.8% | -189.0% | · | -184.4% | -211.4% | -123.0% | · | |
| EBITDA Margin | -120.0% | -69.1% | -60.5% | · | -103.2% | -164.3% | -138.8% | · | -134.6% | -192.1% | -193.8% | · | -194.3% | -221.7% | -127.2% | · | |
| ROA | -6.5% | -4.1% | -3.5% | · | -5.2% | -6.2% | -5.7% | · | -5.1% | -8.4% | -8.6% | · | -8.9% | -10.3% | -7.4% | · | |
| ROE | -21.6% | -12.5% | -10.0% | · | -16.0% | -17.4% | -14.7% | · | -11.7% | -14.3% | -13.6% | · | -13.6% | -12.0% | -8.5% | · | |
| ROIC | -17.1% | -10.2% | -8.9% | · | -23.9% | -24.8% | -20.7% | · | -16.0% | -19.5% | -17.8% | · | -17.3% | -14.7% | -10.0% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.8 | 4.4 | · | 5.0 | 5.3 | 5.5 | · | 4.9 | 6.4 | 6.3 | · | 6.6 | 8.4 | 12.3 | · | |
| Quick Ratio | 0.7 | 0.9 | 1.0 | · | 1.2 | 1.5 | 1.9 | · | 0.8 | 1.3 | 0.8 | · | 1.7 | 2.8 | 2.8 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -10.3 | -12.8 | -10.1 | · | -18.4 | · | · | · |
Efektywność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | |
| Receivables Turnover | 1.9 | 2.4 | 2.3 | · | 2.2 | 2.1 | 2.1 | · | 1.3 | 1.3 | 1.2 | · | 1.0 | 1.0 | 0.9 | · |
Na akcję
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.47 | $4.01 | $4.36 | · | $3.71 | $4.38 | $5.24 | · | $7.03 | $7.84 | $9.07 | · | $11.29 | $12.80 | $14.41 | · | |
| Revenue / Share | $0.49 | $0.59 | $0.65 | · | $0.86 | $0.70 | $0.80 | · | $0.85 | $0.81 | $0.85 | · | $0.90 | $0.85 | $1.13 | · | |
| Cash Flow / Share | · | · | $-0.41 | · | · | · | $-0.79 | · | · | · | $-1.18 | · | · | · | $-1.71 | · | |
| Cash / Share | $1.15 | $1.20 | $1.29 | · | $2.10 | $2.82 | $3.95 | · | $1.69 | $3.00 | $1.89 | · | $4.52 | $3.48 | $2.02 | · | |
| EPS (TTM) | $-2.42 | $-2.60 | $-3.21 | · | $-4.32 | $-4.54 | $-4.95 | · | $-5.46 | $-6.25 | $-6.57 | · | $-6.31 | $-5.98 | $-5.82 | · |
Wycena (TTM)
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $65M | $69M | $67M | · | $65M | $64M | $67M | · | $72M | $73M | $74M | · | $81M | $81M | $82M | · | |
| Net Income TTM | $-63M | $-62M | $-72M | · | $-92M | $-96M | $-105M | · | $-115M | $-132M | $-138M | · | $-132M | $-125M | $-121M | · | |
| Market Cap | $425M | $367M | $458M | · | $162M | $118M | $123M | · | $275M | $370M | $199M | · | $451M | $851M | $972M | · | |
| P/E | -6.0 | -4.9 | -4.9 | · | -1.8 | -1.2 | -1.2 | · | -2.4 | -2.8 | -1.4 | · | -3.4 | -6.8 | -8.0 | · | |
| P/S | 6.5 | 5.3 | 6.8 | · | 2.5 | 1.8 | 1.8 | · | 3.8 | 5.1 | 2.7 | · | 5.6 | 10.5 | 11.8 | · | |
| P/B | 4.2 | 3.1 | 3.6 | · | 2.0 | 1.3 | 1.1 | · | 1.8 | 2.2 | 1.0 | · | 1.9 | 3.2 | 3.2 | · | |
| P / Tangible Book | 4.2 | 3.1 | 3.6 | · | 2.0 | 1.3 | 1.1 | · | 1.8 | 2.2 | 1.0 | · | 1.9 | 3.2 | 3.2 | · | |
| P / Cash Flow | · | · | -39.1 | · | · | · | -7.3 | · | · | · | -8.0 | · | · | · | -27.3 | · | |
| Earnings Yield | -16.6% | -20.6% | -20.4% | · | -57.1% | -82.2% | -86.1% | · | -42.1% | -35.8% | -69.8% | · | -29.5% | -14.8% | -12.5% | · |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Przychody | $65M | $68M | $79M | $86M | $97M |
| Marża Operacyjna % | -130.7% | -179.9% | -173.2% | -143.7% | -112.9% |
| Zysk netto | $-82M | $-116M | $-134M | $-122M | $-79M |
| Rozwodniony EPS | $-3.84 | $-5.48 | $-6.38 | $-5.91 | $-3.92 |
| Wskaźnik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 4.2 | 5.2 | 6.7 | 10.5 | 8.8 |
| Wskaźnik Szybkości | 0.8 | 0.8 | 1.5 | 2.2 | 2.2 |
| Wskaźnik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-32M | $-97M | $-112M | $-87M | $-71M |
Właściciele instytucjonalni (13F) 134 emitenci · $373.6M łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
134
Wartość posiadanych akcji
$373.6M
Nowe pozycje
14
Zamknięte pozycje
19
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 14 (-14 vs poprzedni kw.) | 19 (0 vs poprzedni kw.) | 48 (+1 vs poprzedni kw.) | 37 (+3 vs poprzedni kw.) | -113K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $47 716 934 | 3 784 055 | 12,77% | Akcje |
| BlackRock, Inc. | $47 304 051 | 3 244 448 | 12,66% | Akcje |
| VANGUARD GROUP INC | $36 299 291 | 2 301 794 | 9,72% | Akcje |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $35 257 385 | 2 418 202 | 9,44% | Akcje |
| Deep Track Capital, LP | $21 055 955 | 1 444 167 | 5,64% | Akcje |
| ADAR1 Capital Management, LLC | $19 602 956 | 1 344 510 | 5,25% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $17 667 592 | 1 211 769 | 4,73% | Akcje |
| Spruce Street Capital LP | $15 873 698 | 1 088 731 | 4,25% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $14 747 583 | 1 011 494 | 3,95% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $11 325 842 | 776 634 | 3,03% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $9 389 039 | 643 967 | 2,51% | Akcje |
| STATE STREET CORP | $8 399 786 | 576 117 | 2,25% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $8 129 808 | 557 600 | 2,18% | Akcje |
| Hillsdale Investment Management Inc. | $6 823 440 | 468 000 | 1,83% | Akcje |
| GOLDMAN SACHS GROUP INC | $6 774 583 | 464 649 | 1,81% | Akcje |
| MORGAN STANLEY | $4 603 338 | 315 729 | 1,23% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 390 782 | 301 151 | 1,18% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $4 121 427 | 282 682 | 1,10% | Akcje |
| NORTHERN TRUST CORP | $3 786 368 | 259 696 | 1,01% | Akcje |
| SummitTX Capital, L.P. | $3 757 295 | 257 702 | 1,01% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $3 745 165 | 256 870 | 1,00% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 706 310 | 185 618 | 0,72% | Akcje |
| TWO SIGMA ADVISERS, LP | $2 259 841 | 143 300 | 0,60% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $2 230 857 | 153 008 | 0,60% | Akcje |
| Rockefeller Capital Management L.P. | $2 194 960 | 150 546 | 0,59% | Akcje |
| MARSHALL WACE, LLP | $1 924 487 | 131 995 | 0,52% | Akcje |
| Opaleye Management Inc. | $1 822 500 | 125 000 | 0,49% | Akcje |
| JPMORGAN CHASE & CO | $1 404 045 | 96 764 | 0,38% | Akcje |
| Russell Investments Group, Ltd. | $1 227 255 | 84 231 | 0,33% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $1 190 209 | 81 633 | 0,32% | Akcje |
| Qube Research & Technologies Ltd | $1 181 053 | 81 005 | 0,32% | Akcje |
| Bank of New York Mellon Corp | $1 119 105 | 76 756 | 0,30% | Akcje |
| XTX Topco Ltd | $1 100 323 | 75 468 | 0,29% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $1 037 542 | 71 162 | 0,28% | Akcje |
| Campbell & CO Investment Adviser LLC | $1 031 739 | 70 764 | 0,28% | Akcje |
| Trexquant Investment LP | $1 014 958 | 69 613 | 0,27% | Akcje |
| MACKENZIE FINANCIAL CORP | $982 211 | 67 367 | 0,26% | Akcje |
| SEI INVESTMENTS CO | $972 264 | 66 685 | 0,26% | Akcje |
| UBS Group AG | $937 771 | 64 319 | 0,25% | Akcje |
| Invesco Ltd. | $867 948 | 59 530 | 0,23% | Akcje |
| Nuveen, LLC | $832 970 | 57 131 | 0,22% | Akcje |
| CITADEL ADVISORS LLC | $741 305 | 50 844 | 0,20% | Akcje |
| FRANKLIN RESOURCES INC | $707 393 | 48 518 | 0,19% | Akcje |
| Quantinno Capital Management LP | $657 689 | 45 109 | 0,18% | Akcje |
| Cubist Systematic Strategies, LLC | $598 297 | 49 983 | 0,16% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $596 439 | 40 908 | 0,16% | Akcje |
| PRUDENTIAL FINANCIAL INC | $581 232 | 39 865 | 0,16% | Akcje |
| IEQ CAPITAL, LLC | $561 447 | 38 508 | 0,15% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $507 224 | 34 789 | 0,14% | Akcje |
| RHUMBLINE ADVISERS | $504 034 | 34 571 | 0,13% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Jay R. Luly, Ph.D. ×4 zgłoszenia | 14 lutego 2025 | 7,70% | Aneks | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 26 insiderów · 12 dyrektorzy generalni · 14 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jay R. Luly, Ph.D. | President and CEO | 12 lutego 2026 F | 871 871 | 0 | 1 | $-67 493 |
| Scott T. Rottinghaus | Chief Medical Officer | 8 sierpnia 2026 F | 23 787 | 0 | 1 | $-11 356 |
| Brendan Luu | Chief Business Officer | 12 lutego 2026 F | 41 634 | 0 | 1 | $-19 837 |
| Tara Lynn Kieffer | Chief Product Strategy Officer | 12 lutego 2026 F | 33 925 | 0 | 1 | $-29 968 |
| Matthew Paul Kowalsky | Chief Legal Officer | 12 lutego 2026 F | 3 591 | 0 | 0 | $0 |
| Yat Sun Or | Chief Scientific Officer | 12 lutego 2026 F | 374 854 | 0 | 1 | $-34 010 |
| Kathleen S. Capps | Executive Director of Accounting, Controller (Principal Accounting Officer) | 5 grudnia 2025 S | 8 377 | 0 | 2 | $-7 486 |
| Harry R. Trout III | Vice President, Finance (Principal Financial Officer) | 5 grudnia 2025 S | 16 348 | 0 | 2 | $-13 018 |
| Paul J Mellett | Chief Fin. & Admin Officer | 12 lutego 2025 F | 95 884 | 0 | 0 | $0 |
| Nathaniel S. Gardiner | Chief Legal Officer | 26 lutego 2024 M | 75 688 | 0 | 0 | $0 |
| Nathalie Adda | Sr. VP & Chief Medical Officer | 4 kwietnia 2022 M | 34 982 | 0 | 0 | $0 |
| Tim Ocain | Senior Vice President | 12 lutego 2019 F | 17 547 | 0 | 0 | $0 |
| Yujiro S Hata | Dyrektor | 11 marca 2026 A | · | 0 | 0 | $0 |
| Terry Vance | Dyrektor | 11 marca 2026 A | 5 800 | 0 | 0 | $0 |
| Kristine Peterson | Dyrektor | 11 marca 2026 A | · | 0 | 0 | $0 |
| Lesley Russell | Dyrektor | 11 marca 2026 A | · | 0 | 0 | $0 |
| Mark G Foletta | Dyrektor | 11 marca 2026 A | · | 0 | 0 | $0 |
| Bruce L A Carter | Dyrektor | 11 marca 2026 A | 0 | 0 | 0 | $0 |
| George Golumbeski | Dyrektor | 26 lutego 2020 A | 0 | 0 | 0 | $0 |
| Stephen Buckley Jr. | Dyrektor | 28 lutego 2019 A | 2 000 | 0 | 0 | $0 |
| AFTING ERNST-GUENTER | Dyrektor | 11 lutego 2016 A | 17 287 | 0 | 0 | $0 |
| Helmut Schuhsler | Dyrektor | 24 lutego 2014 S | 1 572 670 | 0 | 0 | $0 |
| Marc E. Goldberg | Dyrektor | 6 grudnia 2013 S | 547 606 | 0 | 0 | $0 |
| Gregory L. Verdine | Dyrektor | 26 marca 2013 P | 3 324 | 0 | 0 | $0 |
| David Poorvin | Dyrektor | 20 marca 2013 A | · | 0 | 0 | $0 |
| SHIONOGI & CO LTD | Posiadacz 10% | 26 marca 2013 C | 1 599 760 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 23 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,51% | 8 992 SH | 1 października 2026 | Dziennie |
| IWC · iShares Trust | 0,08% | 95 810 SH | 11 września 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 80 033 SH | 19 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,03% | 207 553 SH | 11 września 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 2 068 SH | 1 października 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 35 028 SH | 1 października 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 722 462 SH | 11 września 2026 | Dziennie |
| IWO · iShares Trust | 0,01% | 129 551 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 13 537 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 163 048 SH | 19 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12 720 SH | 19 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14 867 SH | 19 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 62 270 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 2 200 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 47 704 SH | 11 września 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,00% | 4 851 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 4 959 SH | 3 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 3 542 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 308 121 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 877 120 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 291 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 1 234 NS | 31 lipca 2026 | N-PORT |
| IWN · iShares Trust | · | 136 586 SH | 11 września 2026 | Dziennie |
ENTA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 12 analityków
KUP
Średni cel
$20.00
+54,3%
4 33,3%
Mocne kupno
7 58,3%
Kup
1 8,3%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
6 analityków · 2026-09-20Średnia cel $21.83 +68,5%
← Poniżej wszystkich celów
Aktualna cena $12.96
Niski$19.00
Średnia$21.83
Wysoki$32.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | · |
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
| EIKN | · | · | · | · | · | · |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 12, 2026